Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment

PLoS Neglected Tropical Diseases

Volumn 6, Issue 7, 2012, Pages

  Landouré, Aly ^a   Dembélé, Robert ^b   Goita, Seydou ^c   Kané, Mamadou ^d   Tuinsma, Marjon ^c   Sacko, Moussa ^a   Toubali, Emily ^c   French, Michael D ^e   Keita, Adama D ^f   Fenwick, Alan ^e   Traoré, Mamadou S ^a,g   Zhang, Yaobi ^c  

^a Institut National de Recherche en Sante Publique Mali   (Mali)

^b MINISTÈRE DE LA SANTÉ   (Mali)

^c HELEN KELLER INTERNATIONAL   (United States)

^d Hospital du Mali   (Mali)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Hopital National du Point G   (Mali)

^g UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADOLESCENT; ARTICLE; CHEMOTHERAPY; CHILD; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; FILTRATION; HUMAN; INFECTION CONTROL; MALE; MALI; MATHEMATICAL MODEL; PREVALENCE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL CHILD; ADULT; ANIMAL; CHEMOPROPHYLAXIS; INFANT; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; NEWBORN; PARASITOLOGY; PATHOLOGY; PRESCHOOL CHILD; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SCHOOL; THEORETICAL MODEL;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MALI; MIDDLE AGED; MODELS, THEORETICAL; PARASITOLOGY; PREVALENCE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SCHOOLS; YOUNG ADULT;

EID: 84864585444     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001774     Document Type: Article

References (38)

1. Chitsulo L, Engels D, Montresor A, Savioli L, ((2000)) The global status of schistosomiasis and its control. Acta Trop 77:: 41--51.
2. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. ((2003)) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86:: 125--139.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, ((2006)) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:: 411--425.
4. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. WHO Technical Report Series 912.
5. WHO (2006) Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions. Geneva: World Health Organization.
6. Richter J, ((2003)) The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 86:: 161--183.
7. Vennervald BJ, Booth M, Butterworth AE, Kariuki HC, Kadzo H, et al. ((2005)) Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. Trans R Soc Trop Med Hyg 99:: 150--160.
8. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, et al. ((2007)) Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 85:: 91--99.
9. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, et al. ((2007)) Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 196:: 659--669.
10. WHO ((2012)) Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol Rec 87:: 37--44.
11. Brinkmann UK, Werler C, Traore M, Korte R, ((1988)) The National Schistosomiasis Control Programme in Mali, objectives, organization, results. Trop Med Parasitol 39:: 157--161.
12. Brinkmann UK, Korte R, Schmidt-Ehry B, ((1988)) The distribution and spread of schistosomiasis in relation to water resources development in Mali. Trop Med Parasitol 39:: 182--185.
13. Traore M, Maude GH, Bradley DJ, ((1998)) Schistosomiasis haematobia in Mali: prevalence rate in school-age children as index of endemicity in the community. Trop Med Int Health 3:: 214--221.
14. Clements AC, Bosque-Oliva E, Sacko M, Landoure A, Dembele R, et al. ((2009)) A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006. PLoS Negl Trop Dis 3:: e431.
15. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. ((2009)) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136:: 1719--1730.
16. Garba A, Toure S, Dembele R, Boisier P, Tohon Z, et al. ((2009)) Present and future schistosomiasis control activities with support from the Schistosomiasis Control Initiative in West Africa. Parasitology 136:: 1731--1737.
17. Dembélé M, Bamani S, Dembélé R, Traoré MO, Goita S, et al. ((2012)) Implementing Preventive Chemotherapy through an Integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis 6:: e1574.
18. Montresor A, Engels D, Chitsulo L, Bundy DA, Brooker S, et al. ((2001)) Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa. Trans R Soc Trop Med Hyg 95:: 542--544.
19. Koukounari A, Sacko M, Keita AD, Gabrielli AF, Landoure A, et al. ((2006)) Assessment of ultrasound morbidity indicators of schistosomiasis in the context of large-scale programs illustrated with experiences from Malian children. Am J Trop Med Hyg 75:: 1042--1052.
20. Koukounari A, Donnelly CA, Sacko M, Keita AD, Landoure A, et al. ((2010)) The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. BMC Infect Dis 10:: 227.
21. Toure S, Zhang Y, Bosque-Oliva E, Ky C, Ouedraogo A, et al. ((2008)) Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ 86:: 780--787.
22. Fulford AJ, ((1994)) Dispersion and bias: can we trust geometric means? Parasitol Today 10:: 446--448.
23. Montresor A, ((2007)) Arithmetic or geometric means of eggs per gram are not appropriate indicators to estimate the impact of control measures in helminth infections. Trans R Soc Trop Med Hyg 101:: 773--776.
24. Chan MS, Guyatt HL, Bundy DA, Booth M, Fulford AJ, et al. ((1995)) The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect 115:: 325--344.
25. Chan MS, Nsowah-Nuamah NN, Adjei S, Wen ST, Hall A, et al. ((1998)) Predicting the impact of school-based treatment for urinary schistosomiasis given by the Ghana Partnership for Child Development. Trans R Soc Trop Med Hyg 92:: 386--389.
26. Macey R, Oster G, Zahnley T, ((2000)) Berkeley Madonna User's Guide. Version 5.0: University of California.
27. Pennycuick L, ((1971)) Frequency distributions of parasites in a population of three-spined sticklebacks, Gasterosteus aculeatus L., with particular reference to the negative binomial distribution. Parasitology 63:: 389--406.
28. Williams BG, Dye C, ((1994)) Maximum likelihood for parasitologists. Parasitol Today 10:: 489--493.
29. Utzinger J, Keiser J, ((2004)) Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 5:: 263--285.
30. Campagne G, Garba A, Barkire H, Vera C, Sidiki A, et al. ((2001)) Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel. Trop Med Int Health 6:: 24--30.
31. Garba A, Campagne G, Tassie JM, Barkire A, Vera C, et al. ((2004)) Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger. Bull Soc Pathol Exot 97:: 7--11.
32. Garba A, Lamine MS, Barkire N, Djibo A, Sofo B, et al. ((2012)) Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni in school-aged children and re-infection patterns in Niger. Acta Trop (in press).
33. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, et al. ((2007)) Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 5:: 27.
34. King CH, Dangerfield-Cha M, ((2008)) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4:: 65--79.
35. Tohon ZB, Mainassara HB, Garba A, Mahamane AE, Bosque-Oliva E, et al. ((2008)) Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren. PLoS Negl Trop Dis 2:: e241.
36. King CH, Dickman K, Tisch DJ, ((2005)) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365:: 1561--1569.
37. WHO (2010) Working to overcome the global impact of neglected tropical diseases- First WHO report on neglected tropical diseases. Geneva: World Health Organization.
38. WHO (2012) Accelerating work to overcome the global impact of neglected tropical diseases- a roadmap for implementation. Geneva: World Health Organization.